Coloplast A (CLPBY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Coloplast A (CLPBY) is down 29.7% since the beginning of the year. At $6 per share, CLPBY is trading 41.1% below its 52-week high of $10. Investors who bought $1,000 worth of CLPBY shares 5 years ago would now be looking at an investment worth $425.

Coloplast A (CLPBY) has returned -29.69% so far this year and -34.36% over the past 12 months. Over the last ten years, CLPBY has returned 0.04% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Jan 13, 2014, CLPBY's average daily return is +0.02%, while the average monthly return is +0.30%. At this rate, an investment would double in approximately 19.3 years.

Historically, 53% of months were positive and 47% were negative. The best month was Feb 2014 with a return of +18.4%, while the worst month was Jan 2022 at -17.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CLPBY closed higher 47% of trading days. The best single day was Feb 9, 2024 with a return of +10.2%, while the worst single day was Nov 2, 2017 at -12.0%.

Coloplast A has an annualized alpha of -1.60%, beta of 0.46, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since January 14, 2014.

• This stock participated in 102.83% of S&P 500 Index downside but only 56.00% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.46 may look defensive, but with R2 of 0.09 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CLPBY ranks 2 for risk / return — in the bottom 2% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Coloplast A (CLPBY) and compare them to S&P 500 Index.

Coloplast A provided a 6.06% dividend yield over the last twelve months, with an annual payout of $0.36 per share. The company has been increasing its dividends for 4 consecutive years.

The table displays the monthly dividend distributions for Coloplast A. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Coloplast A. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Coloplast A was 63.96%, occurring on Jun 2, 2026. The portfolio has not yet recovered.

The current Coloplast A drawdown is 63.96%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Coloplast A over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Coloplast A is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.